Pharmaceuticals News
|
Vermont -
The belief that most drugs in sewage are stashes of illegal narcotics flushed down toilets by criminals appears to be a myth. Most drugs in sewage systems are excreted by people who have been prescribed them.
|
|
In the latest pharmaceutical news round-up there is a new push to eliminate polio, a new treatment for COPD, and unfortunate news that a patient has died after taking an anti-psychotic medication.
|
|
India wants to get in on the oil-for-loans deal that Venezuela has with China, in the hopes of recouping some of the millions of dollars in payments owed to India's largest pharmaceutical companies.
|
|
As we do on a regular basis, Digital Journal has reviewed the latest developments within the pharmaceutical sector. Here AstraZeneca completes takeover of Takeda's respiratory business and Ferring Pharmaceuticals have a new nocturia treatment.
|
|
Washington -
The U.S. public-sector science base, the National Institutes of Health (NIH), has announced it will suspend all research related to sterile medicinal products after the test areas were found to be out of compliance with good practices.
|
|
Pharmaceutical company Novartis experienced mixed results during the first quarter of 2016. Sales showed a decline, however the company is preparing to launch a significant new anti-seizure medication.
|
|
Two very different drugs are making progress in news announced this week. The FDA has approved a new leukemia medication, and work is progressing on a Zika virus treatment.
|
|
This week has seen progress updates issued for new drug products for rheumatoid arthritis, skin dermatitis, and for hepatitis. Each of the products is at the clinical trial stage, and three of the drugs on offer are the result of partnerships.
|
|
The head of GlaxoSmithKline is to retire, amid some concerns about the company’s performance. Digital Journal presents this and other news from the pharmaceutical sector, including mergers and FDA warnings.
|
|
The last couple of years have seen a slight lowering in the number of cases brought against medical companies; however, at the same time, there was an increase in the level of fines paid out.
|
|
As we do at regular intervals, Digital Journal dips into the latest news stories relating to the colorful world of pharmaceuticals. This week there are new drugs announced and old scores to settle.
|
|
By AFP
Brussels -
Belgian federal prosecutors are seeking to bring to court seven pharmaceutical executives accused of supplying a Mexican drug baron with the key ingredients for crystal meth, they said Wednesday.
|
|
Mumbai -
The U.S. Food and Drug Administration has issued a warning notice to Ipca Laboratories, which is based in India, for data integrity issues.
|
|
Human society needs a new generation of antimicrobials to overcome the problem of multi-drug resistance. A key question stemming from this is who should pick up the bill?
|
|
U.S. healthcare colossus Johnson and Johnson saw a drop in its share value by 6 percent during 2015, according to the company’s latest financial statement.
|
|
Washington -
A consent decree has been opened against Downing Labs LLC, of Dallas, Texas, together with the holding company. The action has been initiated by U.S. District Judge Sam A. Lindsay.
|
|
We are only into the early days of 2016 but this hasn’t slowed the actions of companies doing anything to protect their share prices. Two big pharmaceutical companies have already announced plant closures and layoffs.
|
|
Concerns have been expressed over the past few years about the independence of clinical trials, due to the funding of some trials by corporations with vested interests. New data suggests this is now the norm rather than the exception.
|
|
The former, and controversial, CEO of Turing Pharmaceuticals and KaloBios Pharmaceuticals Inc., Martin Shkreli, has been detained for securities fraud.
|
|
In news that will no doubt please the shareholders of pharmaceutical companies, the global spend on drug products is set to rise by 30 percent by the year 2020. This means an annual pay-out of $1.4 trillion.
|
|
London -
The Good Pharma Scorecard is a system that ranks drugs based on their transparency and ethical practices. A review of some big pharma companies reveals several inconsistencies.
|
|
The U.S. Food and Drug Administration (FDA) has placed an import ban on the drug maker Megafine Pharma's Nashik site in Maharashtra, India.
|
|
Most countries do not have any legal limits for the control of pollution from drugs during their manufacture, use and disposal. Some people are now calling for urgent action.
|
|
An investigation has been initiated in New York to see whether Turing Pharmaceuticals has contravened antitrust rules by restricting distribution of the drug Daraprim, as a means to block generic competition.
|
|
Swiss drug giant Roche is to acquire rival company Adheron Therapeutics for $580 million. Adheron Therapeutics are based in the U.S.
|
|
Mumbai -
Pan Drugs Limited of Nandesari, India has been cited by the U.S. FDA for evidence of pigeons in an area of a drug manufacturing facility used to process medications.
|
|
Mumbai -
The company Polydrug Laboratories is no longer able to import medicinal products into the U.S. following a series of concerns about manufacturing standards.
|
|
London -
As part of the growing action against the progressive rise in antibiotic resistant bacteria, two R&D organizations are to work together with the aim of creating new antibiotics.
|
|
Mumbai -
The Indian pharmaceutical sector is beset with compliance problems. This is demonstrated via a series of import bans into the U.S. imposed by the U.S. Food and Drug Administration (FDA).
|
|
Digital Journal delves into the key pharmaceutical sector business news. This week we bring updates from Novartis, Bayer, Boehringer and Lilly.
|
apis-315552 apis-306286 apis-306274 apis-305420 apis-305088 apis-304125 apis-303304 apis-302220 apis-301050 apis-300923 apis-300304 apis-300074 apis-298082 apis-296677 apis-296192 apis-294885 apis-294516 apis-293054 apis-293053 apis-289774 apis-289473 apis-288112 apis-286755 apis-286549 apis-286548 apis-284917 apis-284581 apis-284137 apis-283894 apis-282762
Pharmaceuticals Image
Dr. Olumayokun Olajide's research will now look to produce compound derivatives of punicalagin for a drug that would treat neuro-inflammation, slowing down the progression of Alzheimer's University of Huddersfield
Medicine vials on display at making Pharmaceuticals 2015.
U.S. drug company sues Canada for trying to lower cost of $700K-a-year drug Alexion Pharmaceuticals
Project Team at work: Expertise helps AbbVie develop and enhance products and therapies to treat conditions including HIV, arthritis, immunological and metabolic disorders, heart disease, and cancer. © AbbVie Inc.
Biogen is an American global biotechnology company based in Cambridge, Massachusetts, specializing in the discovery, development, and delivery of therapies for the treatment of neurodegenerative, hematologic, and autoimmune diseases to patients worldwide. Biogen
Sativex contains marijuana-derived ingredients. Associated Press
Eli Lilly's global headquarters, Indianapolis, Indiana Guanaco152003
A variety of statin drugs
|
|
